Paushak Q2 revenue up 52% YoY, PAT jumps 57%
PAUSHAKLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 17.5 pts less than Nifty Microcap 250 and 17.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Paushak Limited reported Q2 FY26 revenue of Rs 8,932 lacs, up about 52% from Rs 5,878 lacs in Q2 FY25. Half year revenue grew around 51% to Rs 17,287 lacs versus Rs 11,466 lacs. PAT for the quarter rose nearly 57% to Rs 1,351 lacs; H1 PAT grew about 39% to Rs 2,862 lacs. EBITDA margin expanded by roughly 480 basis points YoY in Q2. Operating cash flow for H1 stood at Rs 4,072 lacs versus Rs 2,468 lacs last year. CNK and Associates issued an unmodified limited review report.
Strong double-digit revenue and profit growth with healthy cash generation. Positive for shareholders.